Education
About Us
Working with TipRanks
Follow Us
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
Earnings Data
Report Date
Mar 27, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.49Last Year’s EPS
-0.32Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects significant regulatory progress and strong financial positioning through successful funding. However, these positives are counterbalanced by increased losses and rising expenses, primarily due to share-based compensation and trial costs.Company Guidance
Regulatory Progress in Key Markets
Positive feedback from major regulatory agencies, including China's NMPA and the U.K.'s MHRA, agreeing to accept priority and conditional marketing authorization applications based on interim analysis results from the Phase III DRAGON trial.
Successful Funding Initiatives
Completed a $50 million registered direct offering and a $125 million private placement, with the potential for an additional $165 million upon full warrant exercise, resulting in a strong cash position of $275.6 million.
Advancement in Clinical Trials
Completed enrollment of the Phase III PHOENIX trial for GA with 530 subjects and the Phase III DRAGON trial for Stargardt's disease, with ongoing enrollment in the DRAGON II trial.
BLTE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BLTE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 10, 2025 | $117.34 | ― | ― |
Aug 11, 2025 | $69.88 | $69.50 | -0.54% |
May 14, 2025 | $60.89 | $61.60 | +1.17% |
Mar 17, 2025 | $67.44 | $67.81 | +0.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Belite Bio, Inc. ADR (BLTE) report earnings?
Belite Bio, Inc. ADR (BLTE) is schdueled to report earning on Mar 27, 2026, Before Open (Confirmed).
What is Belite Bio, Inc. ADR (BLTE) earnings time?
Belite Bio, Inc. ADR (BLTE) earnings time is at Mar 27, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BLTE EPS forecast?
BLTE EPS forecast for the fiscal quarter 2025 (Q4) is -0.49.